Početna › Autoimune bolesti › Pennsylvania
Kliničke studije za Autoimune bolesti u državi Pennsylvania
21 studija za Autoimune bolesti traži sudionike na lokacijama u državi Pennsylvania.
Gradovi u državi Pennsylvania
Službeni tekst studije (engleski)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UPMC Hillman Cancer Center, Pittsburgh
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT03816345A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program, Philadelphia
- Lewis Katz School of Medicine at Temple University, Philadelphia
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 18. ruj 2026. · NCT06722235A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
- Fox Chase Cancer Center- Temple BMT, Philadelphia
U tijeku regrutacijaFaza 2
Od 16 do 70 godina · Oba spola · Ažurirano 17. ruj 2026. · NCT07328581RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Children's Hospital of Philadelphia - Accepting Young Adult and Juvenile Patients, Philadelphia
- UPMC Children's Hospital of Pittsburgh - Accepting Juvenile Patients, Pittsburgh
- UPMC Arthritis and Autoimmunity Center - Accepting Adult Patients, Pittsburgh
U tijeku regrutacijaFaza 2/3
Od 6 do 75 godina · Oba spola · Ažurirano 17. ruj 2026. · NCT06154252Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
- University of Pittsburgh Medical Center: Division of Rheumatology and Clinical Immunology, Pittsburgh
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 17. ruj 2026. · NCT07103746A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program, Philadelphia
- Lewis Katz School of Medicine at Temple University, Philadelphia
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT06948318A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Philadelphia
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT06572384RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- Children's Hospital of Philadelphia, Philadelphia
U tijeku regrutacijaFaza 1/2
Od 18 do 65 godina · Oba spola · Ažurirano 26. kol 2026. · NCT06121297Abatacept for the Treatment of Giant Cell Arteritis
- University of Pennsylvania, Philadelphia
U tijeku regrutacijaFaza 3
Od 50 godina i više · Oba spola · Ažurirano 20. kol 2026. · NCT04474847A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
- The Children's Hospital of Philadelphia, Philadelphia
U tijeku regrutacijaFaza 3
Od 12 godina i više · Oba spola · Ažurirano 6. kol 2026. · NCT06056297KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
- Thomas Jefferson University Hospital, Philadelphia
U tijeku regrutacijaFaza 2/3
Od 18 do 75 godina · Oba spola · Ažurirano 29. srp 2026. · NCT06193889A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Penn State Milton S. Hershey Cancer Center, Hershey
- Children's Hospital of Philadelphia, Philadelphia
- Children's Hospital of Pittsburgh, Pittsburgh
- i još 3
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 6. srp 2026. · NCT01351545A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
- University of Pennsylvania, Philadelphia
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 29. svi 2026. · NCT04422912A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Jefferson Einstein Hospital Philadelphia, Philadelphia
U tijeku regrutacijaFaza 1
Od 12 do 70 godina · Oba spola · Ažurirano 22. svi 2026. · NCT06308978Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting
- Magee-Womens Hospital, Pittsburgh
U tijeku regrutacija
Sve dobne skupine · Muškarci · Ažurirano 22. tra 2026. · NCT04452305Testicular Tissue Cryopreservation for Fertility Preservation
- Magee-Womens Hospital, Pittsburgh
U tijeku regrutacija
Sve dobne skupine · Muškarci · Ažurirano 22. tra 2026. · NCT02972801Ovarian Tissue Cryopreservation for Fertility Preservation
- Magee-Womens Hospital, Pittsburgh
U tijeku regrutacijaOpažajna studija
Do 39 godina · Žene · Ažurirano 4. ožu 2026. · NCT05875155A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
- Temple University Hospital, Philadelphia
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 25. velj 2026. · NCT06626919Central Vein Sign in Multiple Sclerosis Extension Study
- University of Pennsylvania, Philadelphia
U tijeku regrutacija
Od 18 do 65 godina · Oba spola · Ažurirano 20. velj 2026. · NCT07424027Autoimmunity After Checkpoint Blockade
- University of Pennsylvania - Abramson Cancer Center, Philadelphia
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 8. sij 2026. · NCT04119713X-linked Moesin Associated Immunodeficiency
- Perelman School of medecine, Philadelphia
U tijeku regrutacijaOpažajna studija
Od 4 do 80 godina · Muškarci · Ažurirano 25. tra 2025. · NCT06278337Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.